Effect of baicalein on the expression of VIP in extravillous cytotrophoblasts infected with human cytomegalovirus in vitro

Abstract

This paper aimed to study the ability of baicalein to block human cytomegalovirus (HCMV) infection in extravillous cytotrophoblasts (EVT) and its effect on the vasoactive intestinal peptide (VIP) expression in HCMV-infected EVT in vitro. A human trophoblast cell line (HPT-8) was chosen in this study. HCMV with 100 TCID₅₀ was added into culture medium to infect HPT-8 cells, and then HCMV pp65 antigen was assayed by immunofluorescence staining. The infection status was determined by virus titration. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to detect virus DNA load in the infected cells. The expression of VIP mRNA and protein in the infected cells was measured by qRT-PCR, immunocytochemistry and Western blotting. Concentration of VIP secreted in supernatants was determined by ELISA. Red-stained HCMV pp65 antigens were found in infected HPT-8 cells 48 h after infection. HCMV replicated in large quantity in infected HPT-8 cells 4 days after infection, reaching a peak at day 6 post-infection. After treatment with baicalein, virus DNA load in infected HPT-8 cells was decreased (P<0.05), and the levels of VIP mRNA and protein, and the concentration were raised to the normal (P>0.05). Our study suggested that baicalein exerts a positive effect on the VIP expression in HCMV-infected EVT at maternal-fetal interface.

Keywords

baicalein / human cytomegalovirus / extravillous cytotrophoblasts / vasoactive intestinal peptide

References

[1] RossSA, BoppanaSB. Congenital cytomegalovirus infection: outcome and diagnosis. Semin Pediatr Infect Dis, 2005, 16(1): 44-49

[2] RaynorBD. Cytomegalovirus infection in pregnancy. Semin Perinatol, 1993, 17(6): 394-402

[3] StagnoS, PassRF, CloudG, et al.. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA, 1986, 256(14): 1904-1908

[4] CordierAG, GuittonS, Vauloup-FellousC, et al.. Awareness of cytomegalovirus infection among pregnant women in France. J Clin Virol, 2012, 53(4): 332-337

[5] KumpelBM, ManoussakaMS. Placental immunology and maternal alloimmune responses. Vox Sang, 2012, 102(1): 2-12

[6] FraccaroliL, GrassoE, HaukV, et al.. Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response. Clin Exp Immunol, 2012, 170(3): 310-320

[7] DelgadoM, GaneaD. Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions. Amino Acids, 2011

[8] WarningJC, MccrackenSA, MorrisJM. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction, 2011, 141(6): 715-724

[9] FraccaroliL, AlfieriJ, LaroccaL, et al.. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells. Br J Pharmacol, 2009, 156(1): 116-126

[10] GriffithsPD. The 2001 Garrod lecture. The treatment of cytomegalovirus infection. J Antimicrob Chemother, 2002, 49(2): 243-253

[11] NassettaL, KimberlinD, WhitleyR. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother, 2009, 63(5): 862-867

[12] GaoY, GuZL, JiangXG, et al.. The new research of baicalein pharmacology. Shizhen Guoyi Guoyao (Chinese), 20101765-1767

[13] Yang LP, Yang YM, Yang J, et al. Observations of teratogenic effects of scutellaria baicalensis georgi on embryos of rats. Zhongguo Bijiao Yixue Zazhi (Chinese). (5).

[14] EversDL, ChaoCF, WangX, et al.. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Res, 2005, 68(3): 124-134

[15] CotinS, CallisteCA, MazeronMC, et al.. Eight flavonoids and their potential as inhibitors of human cytomegalovirus replication. Antiviral Res, 2012, 96(2): 181-186

[16] TarradeA, LaiKR, MalassineA, et al.. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Lab Invest, 2001, 81(9): 1199-1211

[17] ZhangL, ZhangW, ShaoC, et al.. Establishment and characterization of a spontaneously immortalized trophoblast cell line (HPT-8) and its hepatitis B virus-expressing clone. Hum Reprod, 2011, 26(8): 2146-2156

[18] LiuT, ZhengX, ChenJ, et al.. Effect of human cytomegalovirus on invasive capability of early pregnant extravillous cytotrophoblasts. J Huazhong Univ Sci Technolog [Med Sci], 2011, 31(6): 819-823

[19] ZhaoJJ, ChenJJ, LiuT, et al.. Anti-viral effects of urosolic acid on guinea pig cytomegalovirus in vitro. J Huazhong Uni Sci Technolog [Med Sci], 2012883-887

[20] ZhaoJJ, ChenSH, FangJG, et al.. Antiviral effects of obeanolic acid on guniea cytomegalovirus in vitro. Lishizhen Med Materia Medica Res (Chinese), 20112862-2864

[21] YinonY, FarineD, YudinMH, et al.. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can, 2010, 32(4): 348-354

[22] MccarthyFP, GilesML, RowlandsS, et al.. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev, 2011D8371

[23] StenqvistAC, ChenT, HedlundM, et al.. An efficient optimized method for isolation of villous trophoblast cells from human early pregnancy placenta suitable for functional and molecular studies. Am J Reprod Immunol, 2008, 60(1): 33-42

[24] DongM, DingG, ZhouJ, et al.. The effect of trophoblasts on T lymphocytes: possible regulatory effector molecules—a proteomic analysis. Cell Physiol Biochem, 2008, 21(5–6): 463-472

[25] RamhorstR, FraccaroliL, AldoP, et al.. Modulation and recruitment of inducible regulatory T cells by first trimester trophoblast cells. Am J Reprod Immunol, 2012, 67(1): 17-27

[26] SaidS I, MuttV. Polypeptide with broad biological activity: isolation from small intestine. Science, 1970, 169(3951): 1217-1218

[27] SpongC Y, LeeSJ, MccuneSK, et al.. Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology, 1999, 140(2): 917-924

[28] MarzioniD, FioreG, GiordanoA, et al.. Placental expression of substance P and vasoactive intestinal peptide: evidence for a local effect on hormone release. J Clin Endocrinol Metab, 2005, 90(4): 2378-2383

[29] ZhaoJJ. . Effective constituents of TCM anti-GPCMV infection experimental study in vitro[D]. Huazhong Uni, 2011

[30] CristeaIM, MoormanNJ, TerhuneSS, et al.. Human cytomegalovirus pUL83 stimulates activity of the viral immediate-early promoter through its interaction with the cellular IFI16 protein. J Virol, 2010, 84(15): 7803-7814